Aclaris Therapeutics (ACRS) Change in Inventory (2018 - 2019)

Aclaris Therapeutics' (ACRS) quarterly Change in Inventory came in at -$3000.0 in Q4 2019, up 99.74% year-on-year from -$1502.0 in Q4 2018, and down 175.0% quarter-over-quarter from $4000.0 in Q3 2019.

Aclaris Therapeutics (ACRS) Change in Inventory (2018 - 2019) Analysis & Trends

Aclaris Therapeutics' Change in Inventory history runs 2 years deep, the most recent figure standing at -$3000.0 for Q4 2019.

  • On a quarterly basis, Change in Inventory rose 99.74% year-over-year to -$3000.0 in Q4 2019; TTM through Dec 2019 was -$605000.0, a N/A change from a year earlier, with the FY2019 full-year figure at -$605000.0, down 493.14% from the prior year.
  • Change in Inventory fell to -$3000.0 in Q4 2019 per ACRS's latest filing, from $4000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $65000.0 in Q1 2019 and bottomed at -$1.1 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 71.84 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 97.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -26.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Aclaris Therapeutics 705.88 Mn 705.88 Mn 1.60 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 -3,000.00
Dec 31, 2019 -3,000.00
Sep 30, 2019 4,000.00
Sep 30, 2019 4,000.00
Jun 30, 2019 -671,000.00
Jun 30, 2019 -671,000.00
Mar 31, 2019 65,000.00
Mar 31, 2019 65,000.00
Dec 31, 2018 -1.15 Mn
Dec 31, 2018 -1.15 Mn
Sep 30, 2018 18,000.00
Sep 30, 2018 18,000.00